Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients

NCT00622869 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

719

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Tacrolimus (reduced tacrolimus)
DRUG: Tacrolimus (tacrolimus elimination)
DRUG: Tacrolimus (tacrolimus control)
DRUG: Everolimus (reduced tacrolimus)
DRUG: Everolimus (tacrolimus elimination)
DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals